Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct 19;12(10):3036.
doi: 10.3390/cancers12103036.

What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers

Efisio Puxeddu  1 , Giovanni Tallini  2 , Roberta Vanni  3
Affiliations
Editorial

What Is New in Thyroid Cancer: The Special Issue of the Journal Cancers

Efisio Puxeddu et al. Cancers (Basel). .

Abstract

The incidence of thyroid cancer has increased over the past 3 to 4 decades. Nonetheless, the mortality from thyroid cancer has remained stable. The thyroid gland may develop nodules encompassing several types of cell proliferation, from frankly benign to very aggressive forms with many intermediate challenging variants. For this reason, there is growing interest in evaluating thyroid nodules from many points of view, from the clinical to the molecular aspects, in the search for innovative diagnostic and prognostic parameters. The aim of this Special Issue was to provide an overview of recent developments in understanding the biology and molecular oncology of thyroid tumors of follicular cell derivation and their repercussions on the diagnosis, prognosis, and therapy. The contributions of many experts in the field made up a Special Issue of Cancers journal, that focusing on different aspects, including mechanistic and functional facets, gives the status of art of clinical and biological perspectives of thyroid cancer.

Keywords: MALDI-MSI; cancer epidemiology; intratumoral heterogeneity; lncRNAs; microcarcinoma; predictive biomarkers; thyroid cancer; thyroid genomics; thyroid transcriptomics; thyroidectomy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Boufraqech M., Nilubol N. Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome. Cancers. 2019;11:1988. doi: 10.3390/cancers11121988. - DOI - PMC - PubMed
    1. Acquaviva G., de Biase D., Diquigiovanni C., Argento C.M., De Leo A., Bonora E., Rhoden K.J., Pession A., Tallini G. BRAF Exon 15 Mutations in Papillary Carcinoma and Adjacent Thyroid Parenchyma: A Search for the Early Molecular Events Associated with Tumor Development. Cancers. 2020;12:430. doi: 10.3390/cancers12020430. - DOI - PMC - PubMed
    1. Fugazzola L., Muzza M., Pogliaghi G., Vitale M. Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance. Cancers. 2020;12:383. doi: 10.3390/cancers12020383. - DOI - PMC - PubMed
    1. Moretti S., Nucci N., Menicali E., Morelli S., Bini V., Colella R., Mandarano M., Sidoni A., Puxeddu E. The Aryl Hydrocarbon Receptor Is Expressed in Thyroid Carcinoma and Appears to Mediate Epithelial-Mesenchymal-Transition. Cancers. 2020;12:145. doi: 10.3390/cancers12010145. - DOI - PMC - PubMed
    1. Minna E., Brich S., Todoerti K., Pilotti S., Collini P., Bonaldi E., Romeo P., De Cecco L., Dugo M., Perrone F., et al. Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers. 2020;12:112. doi: 10.3390/cancers12010112. - DOI - PMC - PubMed

Publication types

LinkOut - more resources